Company Monitoring Page for AbbVie

latest headlines for company on cafepharma

Fear not, AbbVie. Sales king Humira might have a graceful fall from biosim attack: analyst
Fierce Pharma
Tue, 07/13/21 - 11:02 am
Tags:
AbbVie, Humira, patents, biosimilars
The top 15 blockbuster patent expirations coming this decade
Fierce Pharma
Mon, 07/12/21 - 11:05 am
Tags:
patents, patent cliff, AbbVie, Humira, Merck, Keytruda, Bristol Myers Squibb, Revlimid, Pfizer, Eliquis, Regeneron, Eylea, JNJ, Stelara, Opdivo, GSK, Dolutegravir, Ibrance, Januvia, Eli Lilly, Trulicity, Novo Nordisk, Victoza, Amgen, Prolia, Xgeva, Novartis, Cosentyx, Takeda, Entyvio
AbbVie says Rinvoq shines again as maintenance therapy for ulcerative colitis — but safety concerns still loom over JAK class
Endpoints
Wed, 06/30/21 - 10:49 am
Tags:
AbbVie, ulcerative colitis, clinical trials, Rinvoq
Key third-quarter readouts for big pharma
EP Vantage
Tue, 06/29/21 - 10:59 am
Tags:
clinical trials, Pfizer, Roche, idanacogene elaparvovec, Alexion, AstraZeneca, Ultomiris, AbbVie, Rinvoq, Novartis, sabatolimab
AbbVie (ABBV) Announces FDA Will Not Meet PDUFA Action Dates for RINVOQ sNDAs
Street Insider
Fri, 06/25/21 - 11:12 am
Tags:
AbbVie, FDA, Rinvoq, psoriatic arthritis
AbbVie jumps on the BCMA train, opting into TeneoOne buy
Pharmaforum
Thu, 06/24/21 - 12:29 pm
Tags:
AbbVie, TeneoOne, M&A, bispecific antibodies, BCMA
U.S. Supreme Court rebuffs AbbVie appeal in patent fight involving AndroGel drug
Yahoo/Reuters
Mon, 06/21/21 - 10:28 pm
Tags:
AbbVie, Androgel, patents, Perrigo Company, Supreme Court, antitrust
In next-gen BTK battle, AbbVie and J&J tout pivotal data backing Imbruvica as a combo treatment
Endpoints
Mon, 06/14/21 - 10:29 am
Tags:
AstraZeneca, JNJ, AbbVie, clinical trials, CLL, Gazyva, Imbruvica, Venclexta
AbbVie snags another preclinical Parkinson's program with $17M Caraway pact
Fierce Pharma
Wed, 06/9/21 - 10:45 pm
Tags:
AbbVie, Caraway Therapeutics, Parkinson's Disease
Migraines Be Gone: AbbVie’s Atogepant Reduces Headache Frequency and Severity
BioSpace
Fri, 06/4/21 - 10:37 am
Tags:
AbbVie, migraines, atogepant
J&J touts Tremfya win in Humira-resistant psoriatic arthritis patients amid showdown with AbbVie's Skyrizi
Fierce Pharma
Thu, 06/3/21 - 10:51 pm
Tags:
JNJ, Tremfya, psoriatic arthritis, AbbVie, Skyrizi
It's not just pricing and patenting. Now, AbbVie's taxes are the target of congressional scrutiny
Fierce Pharma
Thu, 06/3/21 - 12:07 am
Tags:
AbbVie, taxes, US Congress
AbbVie's Skyrizi takes home a win in late-stage Crohn's study, adding some heft to its expansion plans
Endpoints
Wed, 06/2/21 - 10:55 am
Tags:
AbbVie, Skyrizi, clinical trials, Crohn’s disease
Biohaven earns preventative nod for migraine med Nurtec, snaring a much-needed leg up over AbbVie
Endpoints
Fri, 05/28/21 - 11:16 am
Tags:
Biohaven, FDA, migraines, Nurtec, AbbVie
AbbVie, building out its post-Humira future, posts 5 late-stage trial wins for Skyrizi and Rinvoq
Fierce Pharma
Wed, 05/26/21 - 12:05 pm
Tags:
AbbVie, Humira, drug pricing, patents, immunology, Skyrizi, Rinvoq, clinical trials, Crohn's Disease, atopic dermatitis
Lilly leads the big pharma pack on pipeline value
EP Vantage
Tue, 05/25/21 - 11:04 am
Tags:
Eli Lilly, diabetes, Alzheimer's disease, GSK, AbbVie
AbbVie’s last stand: How an Icelandic billionaire’s biosimilar has one final shot to dethrone Humira
Endpoints
Mon, 05/24/21 - 11:30 pm
Tags:
AbbVie, biosimilars, Humira, Alvotech
Humira patents take center stage as House panel targets AbbVie pricing
BioPharma Dive
Tue, 05/18/21 - 11:23 pm
Tags:
AbbVie, Humira, drug pricing
Alvotech, not content to line up behind other Humira biosims, sues AbbVie over 'wrongful monopoly'
Fierce Pharma
Tue, 05/11/21 - 10:23 pm
Tags:
AbbVie, patents, biosimilars, Humira, Alvotech
An AbbVie clinical vet heading early oncology jumps ship to build his own team at NK cell-focused biotech
Endpoints
Tue, 05/11/21 - 11:10 am
Tags:
Thorsten Graef, Pharmacyclics, AbbVie, oncology, Acepodia, NK cells

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.